Kala Pharmaceuticals Adds 6% In Morning Trade

On:

Shares of Kala Pharmaceuticals, Inc. (KALA) are rising more than 6% Friday morning at $16.43.

The company today said Combangio, Inc., a unit of Kala, has been awarded a $15 million grant by the California Institute for Regenerative Medicine (CIRM) to support the company’s ongoing study of KPI-012 for the treatment of persistent corneal epithelial defect (PCED).

KALA has traded in the range of $3.54-$56.72 in the last 1 year.

Source: Read Full Article

Lates News:
  1. Riding the Crypto Wave: Novogrtz’s Investment Strategy in Uncertain Economic Times
  2. Binance.US Finally Rolls Out Binance Pay Service For US Customers
  3. Capitulation? Bitcoin ($BTC) Whale Holdings Drops to 29-Month Low
  4. Bellerophon Therapeutics Surges 30% On Share Subscription Agreement With An Institutional Investor
  5. Church & Dwight Slips 7% On Tepid Outlook